04309nam 22011533a 450 991034684090332120250203235425.09783039211920303921192710.3390/books978-3-03921-192-0(CKB)4920000000095231(oapen)https://directory.doabooks.org/handle/20.500.12854/52779(ScCtBLL)fdaf91d6-7af4-4660-81f4-05b5d7b3c435(OCoLC)1126125184(oapen)doab52779(EXLCZ)99492000000009523120250203i20192019 uu engurmn|---annantxtrdacontentcrdamediacrrdacarrierMarine Natural Products and ObesityRalph Urbatzka, Vítor VasconcelosMDPI - Multidisciplinary Digital Publishing Institute2019Basel, Switzerland :MDPI,2019.1 electronic resource (194 p.)9783039211913 3039211919 Obesity and related co-morbidities are increasing worldwide and pose a serious health problem. Changes in lifestyle and diet would be the best remedies to fight obesity; however, many people will still rely on medical aid. Marine organisms have been prolific in the production of bioactive compounds for many diseases, e.g., cancer, and promise to be an excellent source for natural-derived molecules and novel nutraceuticals. Bioactive compounds with beneficial activities towards obesity have been described from diverse marine organism including marine algae, bacteria, sponges, fungi, crustaceans or fish. This Special Issue will highlight the progress in the following topics: Bioactive compounds for the treatment of obesity and obesity-related co-morbidities (diabetes, fatty liver, hyperlipidemia) from marine organisms; the isolation of novel compounds, the bioactivity screening of marine organisms and the elucidation of molecular mode of action of marine bioactive compounds.Medicinebicsscnatural compoundsanti-obesity drugshigh fat dietIshige okamuraefatzebrafish Nile red fat metabolism assayphysical exerciseJAK2-STAT3metabolite profilingobesitychlorophyll derivativesbrown seaweedSkate skinPPAR?marine algamarine biodiscoveryskate skinlipolyticleptinuncoupling protein 13T3-L1 cellsglucolipid metabolism disordernutritionbioactivitychitosan oligosaccharidediphlorethohydroxycarmalol (DPHC)nutraceuticalswhole small animal modelshigh-fat dietadipocytedyslipidemiabioactivity screeningperoxisome proliferator-activated receptor gammawhite adipose tissueantiobesityfatty liver diseasethermal proteome profilinginflammationcyanobacteriaRaja kenojeiArthrospira maximacellularityadipocytesbioactive compoundcollagen peptidedouble-blindbisabolane-related compoundsproliferationfatty acid metabolismcholesterol metabolismcollagenrandomized controlled trialmechanisms of actionmurine pre-adipocytesadipogenesisfucanmarine spongeslabel-free quantitative proteomicsdiabetesbody fatMedicineUrbatzka Ralph1787725Vasconcelos VítorScCtBLLScCtBLLBOOK9910346840903321Marine Natural Products and Obesity4321350UNINA